BioDiem Limited

Press Releases

2013-October-28	Delisting Update (in PDF)
2013-October-24	China Presentation of BioDiem's Liver Treatment Technology (in PDF)
2013-October-8	Chairman's Address to Shareholders (in PDF)
2013-September-16	BDM-I Study Results Presented at Interscience Conference (in PDF)
2013-September-6	Chairman's Letter to Shareholders (in PDF)
2013-August-30	Proposed Delisting from ASX (in PDF)
2013-August-27	Commentary - Full Year Results (in PDF)
2013-August-23	BioDiem US Patent for Skin and Wound Infections (in PDF)
2013-July-22	Proof of Principle Shown in Liver Disease Vaccine Program (in PDF)
2013-July-11	Griffith Uni Study Enhances BioDiem's Antimicrobial Program (in PDF)
2013-June-19	BioDiem's Asia Biotech Invest 2013 Video Presentation (in PDF)
2013-June-4	BioDiem to Present at Hong Kong Biotech Investment Forum (in PDF)
2013-May-22	New Japanese Protozoal Patent for BDM-I (in PDF)
2013-May-10	BDM-I Progress in NIH Research Program as Fungal Infection Treatment (in PDF)
2013-April-5	Van Leeuwenhoeck Research Publishes Updated Analyst Report (in PDF)
2013-February-21	Additional Antimicrobial Patent Granted in China (in PDF)
2013-February-21	BioDiem Releases Half Year Results (in PDF)
2013-February-14	BioDiem Extends Co-Operative Agreement with USAMRIID (in PDF)
2013-February-12	Chinese Vaccine Partner Pays Annual License Fee Early (in PDF)
2013-February-8	Progress to POC Testing of BDM-I Effect against Parasites (in PDF)
2013-February-7	Change of Registered Office (in PDF)
2013-February-1	BioDiem's Antimicrobial Continues in US NIH Program (in PDF)
2015	2015 Press Releases
2014	2014 Press Releases
2012	2012 Press Releases